استخدام الريتودرين في تثبيط المخاض الباكر

Authors

  • أحمد عبد الرحمن
  • جهاد أيوب
  • طلال صالح

Abstract

أجريت هذه الدراسة على مريضات المخاض الباكر من 28 وحتى 33 أسبوع حملي حيث بلغ عدد المريضات 57 وقد تم استبعاد 7 مريضات لوجود مضاد استطباب أو وجود مخاض متقدم . استخدم العلاج بالريتودرين (تسريب وريدي) على خمسين مريضة مخاض باكر , حيث بلغت نسبة النجاح 70% في حين بلغت نسبة الفشل 30% . هذا واشتملت الآثار الجانبية التي حدثت أثناء العلاج على تسرع النبض والخفقان بنسبة 54%, الزلة التنفسية 38% ,الرجفان 16% , تسرع قلب الجنين 4% ولم تلاحظ آثار جانبية خطيرة.

ارتفعت نسبة الآثار الجانبية عند وجود عامل خطر أو أكثر عند المريضة كما في ارتكاز المشيمة المعيب 50% , فقر دم 68.75% , انبثاق أغشية باكر 53.84%  حمل توأمي 80% , الوزن أقل من 50كغ 40% , والخروس 50% .

This study included 57 patients of preterm labor. Patients' gestational age ranged between 28 and 33 weeks. 7 patients were excluded from this study because of contraindications, so the remainder 50 patients received i. v. Ritodrin injection. The results were as follows: (a) success rate was 70%, (b) failure rate was 30% (c);side-effects were: Tachycardia 54%, dyspnoca 38%, tremor 16%, and fetal Tachycardia 4%; all side-effects increased up to 75% when patients suffered from Anemia 68.75%, Placenta previa 50%, prom 53.84%, and multi-fetal pregnancy 80%.

Downloads

Published

2019-01-17

How to Cite

1.
عبد الرحمن أ, أيوب ج, صالح ط. استخدام الريتودرين في تثبيط المخاض الباكر. Tuj-hlth [Internet]. 2019Jan.17 [cited 2024Apr.30];30(5). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/6586

Issue

Vol. 30 No. 5 (2008): العلوم الصحية

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)

1 2 3 > >>